J. L. Ader
YOU?
Author Swipe
View article: Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma
Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma Open
Spleen size may serve as a promising prognostic marker in CAR T-cell therapy for RRMM patients, providing a simple and readily accessible tool for enhancing risk stratification. This finding could inform monitoring strategies and optimize …
View article: Publisher Correction: Predicting progression events in multiple myeloma from routine blood work
Publisher Correction: Predicting progression events in multiple myeloma from routine blood work Open
8